DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Alicaforsen
Alicaforsen
A Lower Risk, Higher Value, Late-Stage Pipeline for Gastrointestinal Diseases
Alicaforsen, an Antisense Inhibitor of ICAM-1, As Treatment for Left- Sided Ulcerative Colitis and Ulcerative Proctitis
Informed Consent
LAY SUMMARY CLINICAL RESEARCH PROTOCOL ACH UCP-301 Eudract Number 2013-002952-34 IND Number 64,905
Alicaforsen for Pouchitis – Second Line
Alicaforsen (ISIS 2302) Improves Clinical Symptoms of Pouchitis Patients
Clinical Trial of Alicaforsen for Patients with Antibiotic Refractory Pouchitis
Isis Pharmaceuticals Initiates Phase II Clinical Trial of Alicaforsen, ISIS 2302, in Patients with Ulcerative Colitis
Alicaforsen for Active Ulcerative Colitis – Second Line
A Survey of Commercial Biomolecules, Delimited to Pharmaceuticals and Medical Devices
Biological Therapies in Inflammatory Bowel Disease Beyond Anti-TNF Therapies
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
Clinical Trial of Alicaforsen for Patients with Antibiotic Refractory Pouchitis Atlantic Pharmaceuticals Ltd Is Alerting Pouchitis Patients to a New Study
A Randomised, Controlled, Double Blind, Escalating Dose Study of Alicaforsen Enema in Active Ulcerative Colitis
Nešpecifické Zápaly Čreva Inflammatory Bowel Disease
Top View